Transgenic Group Inc. (TYO:2342)
Japan · Delayed Price · Currency is JPY 289.00
-1.00 (-0.34%)
At close: Mar 6, 2026
Transgenic Group Market Cap
Transgenic Group has a market cap or net worth of 4.81 billion as of March 6, 2026. Its market cap has increased by 59.67% in one year.
Market Cap
4.81B
Enterprise Value
5.52B
Revenue
12.89B
Ranking
n/a
PE Ratio
n/a
Stock Price
289.00
Market Cap Chart
Since July 2, 2003, Transgenic Group's market cap has decreased from 9.78B to 4.81B, a decrease of -50.78%. That is a compound annual growth rate of -3.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 4.81B | -5.25% |
| Dec 30, 2025 | 5.08B | 73.30% |
| Dec 30, 2024 | 2.93B | -33.27% |
| Dec 29, 2023 | 4.39B | -20.08% |
| Dec 30, 2022 | 5.50B | -27.38% |
| Dec 30, 2021 | 7.57B | -5.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chiome Bioscience | 7.43B |
| Linical | 7.16B |
| PRISM BioLab Co.,LTD | 7.13B |
| Noile-Immune Biotech | 6.58B |
| Soiken Holdings | 6.54B |
| TMS Co., Ltd. | 6.50B |
| Carna Biosciences | 6.29B |
| Kohjin Bio | 6.23B |